Resúmenes comentados

• Rafel Alcubierre ^[1] ; I. Ayet ; A. Filloy ; M. Fortuny ; V. Martín ; E. Pascual ; J. Téllez
  1. [1] Hospital General de l'Hospitalet

     Hospital General de l'Hospitalet

     l'Hospitalet de Llobregat, España

     
• Localización: Annals d'oftalmologia: òrgan de les Societats d'Oftalmologia de Catalunya, Valencia i Balears, ISSN-e 1133-7737, Vol. 30, Nº. 3, 2022
• Idioma: español

• Es reseña de:

  • Outcomes of bilateral cataract surgery in children 2-7 years of age: a comparison to surgery in toddlers and infants

    C. Adams, AA Alex, RH Trivedi, ME Wilson

    JAAPOS, Vol. 26, Núm. 3, 2022

  • Interocular differences in subfoveal choroidal thickness in monocular intermittent exotropia

    Ho Na Jeong, Lee Soo Jung

    JAAPOS, Vol. 26, Núm. 3, 2022

  • Outcomes in primary uncomplicated rhegmatogenous retinal detachment repair using pars plana vitrectomy with or without scleral buckle

    M Hébert, E You, J Garneau, S Ruyu Qi, S Bourgault, M Caissie,

    Retina, Vol. 42, Núm. 6, 2022

  • Three-year treatment outcomes of aflibercept versus ranibizumab for diabetic macular edema: Data from the Fight Retinal Blindness! Registry

    PH Gabrielle, V Nguyen, C Creuzot-Garcher, JJ Arnold, H Mehta, M Asencio Duran

    Retina, Vol. 42, Núm. 6, 2022

  • Predictors of retinal pigment epithelium tear development after treatment for neovascular age-related macular degeneration using swept source optical coherence tomography angiography

    S Yasuhara, M Miyata, S Ooto, H Tamura, N Ueda-Arakawa, A Uji

    Retina, Vol. 42, Núm. 6, 2022

  • Orange palpebral spots

    S Blannett, SM Swink, SM Purcell

    Journal of Osteopathic Medicine, Vol. 121, Núm. 7, 2021

  • Eight months follow-up of corneal nerves and sensitivity after treatment with cenegermin for neurotrophic keratopathy

    E. Pedrotti, E. Bonacci, Ch. Chierego, A. De Gregorio, T. Cozzini, T. Brighenti

    Orphanet Journal of Rare Diseases, 2022

  • Results from a Prospective, Open-Label, Phase 4 Pilot Study of Repository Corticotropin Injection for Moderate and Severe Dry Eye Disease

    M. Toyos, R. Toyos, B. Jodoin, R. Bunch

    Ophthalmology and therapy, Núm. 11, 2022

  • Proptosis and diplopia response with teprotumumab and placebo vs the recommended treatment regimen with intravenous methylprednisolone in moderate to severe thyroid eye disease. A meta-analysis and matching-adjusted indirect comparison

    RS Douglas, PS Subramanian, G Barbesino, S Ugradar, R Batten, RA Qadeer, C. Cameron

    JAMA ophthalmology, Vol. 140, Núm. 4, 2022

  • Dominant Optic Atrophy: How to determine the pathogenicity of novel variants?

    JA Zehden, S Raviskanthan, PW Mortensen, M Ferré, P Reynier, D Milea, AG. Lee

    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, Núm. 42, 2022

  • Does Tocilizumab Influence Ophthalmic Outcomes in Giant Cell Arteritis?

    MA Bouffard, S Prasad, S Unizony, F Costello

    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, Núm. 42, 2022

  • Patterns of Visual Field Loss in Early, Moderate, and Severe Stages of Open Angle Glaucoma

    RAS Germano, CS Germano, FN Susanna, R Susanna

    Journal of glaucoma, Vol. 31, Núm. 7, 2022

  • Energy Dose-Response in Selective Laser Trabeculoplasty: A Review

    N Radcliffe, G Gazzard, T Samuelson, P Khaw, X Sun, T Aung

    1057-0829, Vol. 31, Núm. 8, 2022

• Texto completo no disponible (Saber más ...)